- Home
- NAMS vs SHOO Comparison
NAMS vs SHOO Comparison
Compare NAMS & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | SHOO |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | NAMS | SHOO |
|---|---|---|
| Price | $35.72 | $42.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $46.40 | $41.00 |
| AVG Volume (30 Days) | ★ 1.0M | 981.5K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | $35,243,000.00 | ★ $2,362,727,000.00 |
| Revenue This Year | N/A | $13.10 |
| Revenue Next Year | N/A | $11.74 |
| P/E Ratio | ★ N/A | $54.77 |
| Revenue Growth | 4.91 | ★ 6.41 |
| 52 Week Low | $14.06 | $19.05 |
| 52 Week High | $42.00 | $44.99 |
Technical Indicators
Market Signals| Indicator | NAMS | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 55.56 |
| Support Level | $32.85 | $42.43 |
| Resistance Level | $37.00 | $43.90 |
| Average True Range (ATR) | 1.56 | 1.17 |
| MACD | -0.04 | -0.37 |
| Stochastic Oscillator | 61.40 | 12.89 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.